Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex–mediated acute lupus glomerulonephritis

Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) dep...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 210; no. 11; pp. 2387 - 2401
Main Authors Ge, Yan, Jiang, Chao, Sung, Sun-Sang J., Bagavant, Harini, Dai, Chao, Wang, Hongyang, Kannapell, Carol C., Cathro, Helen P., Gaskin, Felicia, Man Fu, Shu
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 21.10.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti–mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented.
AbstractList Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti–mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented.
Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti-mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented.Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti-mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented.
The mechanisms regulating acute and chronic glomerulonephritis are dependent on different genetic mechanisms, where the Cgnz1 allele confers kidney protection in immune complex-mediated proliferative lupus nephritis.
The mechanisms regulating acute and chronic glomerulonephritis are dependent on different genetic mechanisms, where the Cgnz1 allele confers kidney protection in immune complex–mediated proliferative lupus nephritis. Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti–mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented.
Author Gaskin, Felicia
Wang, Hongyang
Jiang, Chao
Bagavant, Harini
Dai, Chao
Man Fu, Shu
Cathro, Helen P.
Ge, Yan
Sung, Sun-Sang J.
Kannapell, Carol C.
AuthorAffiliation 1 Division of Rheumatology and Immunology and 2 Center of Immunity, Inflammation and Regenerative Medicine, Department of Medicine ; 3 Department of Microbiology, Immunology and Cancer Biology ; 4 Division of Nephrology, Department of Medicine ; 5 Department of Pharmacology ; 6 Department of Pathology ; and 7 Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, VA 22908
AuthorAffiliation_xml – name: 1 Division of Rheumatology and Immunology and 2 Center of Immunity, Inflammation and Regenerative Medicine, Department of Medicine ; 3 Department of Microbiology, Immunology and Cancer Biology ; 4 Division of Nephrology, Department of Medicine ; 5 Department of Pharmacology ; 6 Department of Pathology ; and 7 Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, VA 22908
Author_xml – sequence: 1
  givenname: Yan
  surname: Ge
  fullname: Ge, Yan
– sequence: 2
  givenname: Chao
  surname: Jiang
  fullname: Jiang, Chao
– sequence: 3
  givenname: Sun-Sang J.
  surname: Sung
  fullname: Sung, Sun-Sang J.
– sequence: 4
  givenname: Harini
  surname: Bagavant
  fullname: Bagavant, Harini
– sequence: 5
  givenname: Chao
  surname: Dai
  fullname: Dai, Chao
– sequence: 6
  givenname: Hongyang
  surname: Wang
  fullname: Wang, Hongyang
– sequence: 7
  givenname: Carol C.
  surname: Kannapell
  fullname: Kannapell, Carol C.
– sequence: 8
  givenname: Helen P.
  surname: Cathro
  fullname: Cathro, Helen P.
– sequence: 9
  givenname: Felicia
  surname: Gaskin
  fullname: Gaskin, Felicia
– sequence: 10
  givenname: Shu
  surname: Man Fu
  fullname: Man Fu, Shu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24101379$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1rFjEUhYNU7NvqzrVk6cKpySQzk9kI8uIXFNzoOmSSO9PUfIxJplhXgj_Bf-gvMaUfqLhwlQt5zuEc7j1CByEGQOgxJSeUCP78HPxJSygjA6P30I52nDRjx8QB2hHStg0lZDhERzmfE0I57_oH6LDltCqGcYe-75fwlWLlHDjAOoYZUsafrAlwiRNkm4sKGnCJ2CivFsBrggsIxYaljnGpTLYx4Dhj6_0Wrkz86uDLz28_PBirChis9FYAu23dMl5c9JA2V1usZ8kWmx-i-7NyGR7dvMfo4-tXH_Zvm9P3b97tX542mgtWGjOqmc29ocM8KJj4OIlOCaa5moSYDJ9Yb3g3gABmesEG3Y-8m_VQVaNWZmDH6MW177pNNZquLZJyck3Wq3Qpo7Lyz59gz-QSLyQThI-cVYOnNwYpft4gF-lt1uCcChC3LGnX0Z4T0f8HyjlnY8t4W9Env8e6y3O7pAo8uwZ0ijknmO8QSuTVDch6A_L2Bire_oVrW1SpS6qlrPu36Be4VLqh
CitedBy_id crossref_primary_10_1016_j_jaut_2019_05_005
crossref_primary_10_1016_j_molmed_2017_05_006
crossref_primary_10_1172_JCI142428
crossref_primary_10_1002_art_40155
crossref_primary_10_1016_j_clim_2014_06_008
crossref_primary_10_1016_j_coi_2014_10_004
crossref_primary_10_1136_ard_2022_222495
crossref_primary_10_3389_fimmu_2023_1147526
crossref_primary_10_3389_fimmu_2019_00672
crossref_primary_10_1038_nrneph_2015_33
crossref_primary_10_1038_s41590_020_0677_6
crossref_primary_10_1016_j_clim_2021_108675
crossref_primary_10_1016_j_jaut_2019_102331
crossref_primary_10_1002_art_38679
crossref_primary_10_3389_fphar_2021_806612
crossref_primary_10_1038_nrneph_2017_34
crossref_primary_10_1038_s41581_023_00786_x
crossref_primary_10_1093_rheumatology_kew400
crossref_primary_10_1016_j_clim_2017_05_015
crossref_primary_10_12688_f1000research_10445_1
crossref_primary_10_1038_nrrheum_2015_159
crossref_primary_10_1016_j_clim_2014_11_003
crossref_primary_10_1038_nrrheum_2015_178
crossref_primary_10_1016_j_molmed_2018_02_003
crossref_primary_10_1084_jem_20170479
crossref_primary_10_1016_j_clim_2016_07_024
crossref_primary_10_1002_eji_202149324
crossref_primary_10_1093_ndt_gfv374
crossref_primary_10_1093_ndt_gfv396
crossref_primary_10_3904_kjim_2017_383
crossref_primary_10_1186_s12964_024_01681_z
crossref_primary_10_1111_imr_12373
crossref_primary_10_1136_annrheumdis_2018_214125
crossref_primary_10_4049_jimmunol_1601565
crossref_primary_10_1016_j_clim_2024_109939
crossref_primary_10_1038_nrrheum_2016_186
Cites_doi 10.1038/gene.2012.57
10.1038/sj.ki.5001988
10.1056/NEJMra071297
10.1016/1074-7613(94)90100-7
10.1016/S0065-2776(08)60342-9
10.1084/jem.20031519
10.1007/s00281-007-0097-9
10.1002/art.1780251101
10.4049/jimmunol.175.11.7185
10.4049/jimmunol.180.3.1938
10.1056/NEJMra1100359
10.1126/science.279.5353.1052
10.4049/jimmunol.177.11.8258
10.1002/eji.1830190515
10.1002/art.10887
10.1006/clim.2001.5079
10.4049/jimmunol.177.4.2671
10.1002/art.1780400928
10.1038/ng.975
10.1016/B978-0-12-394299-9.00004-7
10.4049/jimmunol.167.4.2354
10.1073/pnas.97.12.6670
10.1007/s00281-003-0121-7
10.1002/art.34380
10.1097/00005792-197711000-00004
10.3899/jrheum.080625
10.1073/pnas.98.4.1787
10.1084/jem.161.2.378
10.1126/science.1125893
10.4049/jimmunol.1003010
10.1002/acr.21664
ContentType Journal Article
Copyright 2013 Ge et al. 2013
Copyright_xml – notice: 2013 Ge et al. 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
8FD
FR3
H94
P64
RC3
5PM
DOI 10.1084/jem.20130731
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Genetics Abstracts
Immunology Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Genetics of lupus glomerulonephritis progression
EISSN 1540-9538
EndPage 2401
ExternalDocumentID PMC3804943
24101379
10_1084_jem_20130731
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: R01 AR049449
– fundername: NIAMS NIH HHS
  grantid: R01 AR047988
– fundername: NIAID NIH HHS
  grantid: R01-AI079621
– fundername: NIAMS NIH HHS
  grantid: P50 AR045222
– fundername: NIAID NIH HHS
  grantid: R01 AI079621
– fundername: NIAMS NIH HHS
  grantid: P50-AR04522
– fundername: NIAMS NIH HHS
  grantid: R01-AR047988
– fundername: NIAMS NIH HHS
  grantid: R01-AR049449
GroupedDBID ---
-~X
0VX
18M
29K
2WC
36B
4.4
53G
5GY
5RE
5VS
AAYXX
ABOCM
ABZEH
ACGFO
ACNCT
ACPRK
ADBBV
AENEX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C45
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
F9R
GX1
H13
HYE
IH2
K-O
KQ8
L7B
N9A
O5R
O5S
OK1
P2P
P6G
R.V
RHI
SJN
TR2
TRP
UHB
W8F
WOQ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
8FD
FR3
H94
P64
RC3
5PM
ID FETCH-LOGICAL-c483t-d9af3f6d17f7aeb49b85a83c4ab88bd4b36d457e8e3d6837c6945fc7af39cad73
ISSN 0022-1007
1540-9538
IngestDate Thu Aug 21 14:37:25 EDT 2025
Fri Jul 11 15:57:24 EDT 2025
Fri Jul 11 12:37:22 EDT 2025
Mon Jul 21 05:20:25 EDT 2025
Thu Apr 24 23:11:04 EDT 2025
Tue Jul 01 03:30:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c483t-d9af3f6d17f7aeb49b85a83c4ab88bd4b36d457e8e3d6837c6945fc7af39cad73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
C. Jiang’s present address is Molecular Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20814.
Y. Ge’s present address is Genetics Institute, University of Florida, Gainesville, FL 32610.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3804943
PMID 24101379
PQID 1444392342
PQPubID 23479
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3804943
proquest_miscellaneous_1551640863
proquest_miscellaneous_1444392342
pubmed_primary_24101379
crossref_primary_10_1084_jem_20130731
crossref_citationtrail_10_1084_jem_20130731
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-10-21
PublicationDateYYYYMMDD 2013-10-21
PublicationDate_xml – month: 10
  year: 2013
  text: 2013-10-21
  day: 21
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of experimental medicine
PublicationTitleAlternate J Exp Med
PublicationYear 2013
Publisher The Rockefeller University Press
Publisher_xml – name: The Rockefeller University Press
References Xie (2023072603061035200_bib32) 2003; 48
Rahman (2023072603061035200_bib20) 2008; 358
Tipping (2023072603061035200_bib26) 2003; 24
Morel (2023072603061035200_bib16) 2012; 115
Morel (2023072603061035200_bib17) 1994; 1
Bjorndahl (2023072603061035200_bib4) 1989; 19
Bagavant (2023072603061035200_bib2) 2006; 177
Shimizu (2023072603061035200_bib23) 2005; 175
Ward (2023072603061035200_bib28) 2009; 36
Clynes (2023072603061035200_bib5) 1998; 279
Theofilopoulos (2023072603061035200_bib25) 1985; 37
Waters (2023072603061035200_bib29) 2001; 100
Tan (2023072603061035200_bib24) 1982; 25
Hahn (2023072603061035200_bib7) 2012; 64
Kumar (2023072603061035200_bib12) 2006; 312
Al-Mayouf (2023072603061035200_bib1) 2011; 43
Lawson (2023072603061035200_bib13) 2001; 167
Bethunaickan (2023072603061035200_bib3) 2011; 186
Dooley (2023072603061035200_bib6) 2011
Morel (2023072603061035200_bib18) 2000; 97
Mahajan (2023072603061035200_bib14) 1977; 56
Mohan (2023072603061035200_bib15) 1998; 101
Xie (2023072603061035200_bib33) 2013; 14
Keppler (2023072603061035200_bib11) 2007; 71
Jacob (2023072603061035200_bib10) 2006; 177
Schiffer (2023072603061035200_bib22) 2008; 180
Waters (2023072603061035200_bib30) 2004; 199
Tsokos (2023072603061035200_bib27) 2011; 365
Holdsworth (2023072603061035200_bib9) 2007; 29
Morel (2023072603061035200_bib19) 2001; 98
Satoh (2023072603061035200_bib21) 2012; 64
Hochberg (2023072603061035200_bib8) 1997; 40
Wofsy (2023072603061035200_bib31) 1985; 161
11513551 - Clin Immunol. 2001 Sep;100(3):372-83
22129255 - N Engl J Med. 2011 Dec 1;365(22):2110-21
9461440 - Science. 1998 Feb 13;279(5353):1052-4
19004042 - J Rheumatol. 2009 Jan;36(1):63-7
9324032 - Arthritis Rheum. 1997 Sep;40(9):1725
11490025 - J Immunol. 2001 Aug 15;167(4):2354-60
18305268 - N Engl J Med. 2008 Feb 28;358(9):929-39
11172029 - Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1787-92
3890479 - Adv Immunol. 1985;37:269-390
22237992 - Arthritis Rheum. 2012 Jul;64(7):2319-27
17938927 - Semin Immunopathol. 2007 Nov;29(4):355-74
14718514 - J Exp Med. 2004 Jan 19;199(2):255-64
9502778 - J Clin Invest. 1998 Mar 15;101(6):1362-72
16778059 - Science. 2006 Jun 16;312(5780):1665-9
21411733 - J Immunol. 2011 Apr 15;186(8):4994-5003
22556106 - Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808
18209092 - J Immunol. 2008 Feb 1;180(3):1938-47
16888029 - J Immunol. 2006 Aug 15;177(4):2671-80
12778334 - Springer Semin Immunopathol. 2003 May;24(4):377-93
12687552 - Arthritis Rheum. 2003 Apr;48(4):1080-92
2544432 - Eur J Immunol. 1989 May;19(5):881-7
335188 - Medicine (Baltimore). 1977 Nov;56(6):493-501
16301622 - J Immunol. 2005 Dec 1;175(11):7185-92
3919141 - J Exp Med. 1985 Feb 1;161(2):378-91
7889410 - Immunity. 1994 Jun;1(3):219-29
17082757 - Kidney Int. 2007 Jan;71(1):74-8
17114504 - J Immunol. 2006 Dec 1;177(11):8258-65
10841565 - Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6670-5
22019780 - Nat Genet. 2011 Dec;43(12):1186-8
22608257 - Adv Immunol. 2012;115:113-39
23392277 - Genes Immun. 2013 Apr;14(3):170-8
7138600 - Arthritis Rheum. 1982 Nov;25(11):1271-7
References_xml – volume: 14
  start-page: 170
  year: 2013
  ident: 2023072603061035200_bib33
  article-title: Lupus-prone strains vary in susceptibility to antibody-mediated end organ disease
  publication-title: Genes Immun.
  doi: 10.1038/gene.2012.57
– volume: 71
  start-page: 74
  year: 2007
  ident: 2023072603061035200_bib11
  article-title: Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay
  publication-title: Kidney Int.
  doi: 10.1038/sj.ki.5001988
– volume: 358
  start-page: 929
  year: 2008
  ident: 2023072603061035200_bib20
  article-title: Systemic lupus erythematosus
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra071297
– volume: 1
  start-page: 219
  year: 1994
  ident: 2023072603061035200_bib17
  article-title: Polygenic control of susceptibility to murine systemic lupus erythematosus
  publication-title: Immunity.
  doi: 10.1016/1074-7613(94)90100-7
– volume: 37
  start-page: 269
  year: 1985
  ident: 2023072603061035200_bib25
  article-title: Murine models of systemic lupus erythematosus
  publication-title: Adv. Immunol.
  doi: 10.1016/S0065-2776(08)60342-9
– volume: 199
  start-page: 255
  year: 2004
  ident: 2023072603061035200_bib30
  article-title: Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20031519
– volume: 29
  start-page: 355
  year: 2007
  ident: 2023072603061035200_bib9
  article-title: Leukocytes in glomerular injury
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-007-0097-9
– volume: 25
  start-page: 1271
  year: 1982
  ident: 2023072603061035200_bib24
  article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.1780251101
– volume: 175
  start-page: 7185
  year: 2005
  ident: 2023072603061035200_bib23
  article-title: Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1)
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.175.11.7185
– volume: 180
  start-page: 1938
  year: 2008
  ident: 2023072603061035200_bib22
  article-title: Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.3.1938
– volume: 365
  start-page: 2110
  year: 2011
  ident: 2023072603061035200_bib27
  article-title: Systemic lupus erythematosus
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1100359
– volume: 279
  start-page: 1052
  year: 1998
  ident: 2023072603061035200_bib5
  article-title: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis
  publication-title: Science.
  doi: 10.1126/science.279.5353.1052
– volume: 177
  start-page: 8258
  year: 2006
  ident: 2023072603061035200_bib2
  article-title: Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.177.11.8258
– volume: 19
  start-page: 881
  year: 1989
  ident: 2023072603061035200_bib4
  article-title: Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.1830190515
– volume: 48
  start-page: 1080
  year: 2003
  ident: 2023072603061035200_bib32
  article-title: Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.10887
– volume: 100
  start-page: 372
  year: 2001
  ident: 2023072603061035200_bib29
  article-title: NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci
  publication-title: Clin. Immunol.
  doi: 10.1006/clim.2001.5079
– volume: 177
  start-page: 2671
  year: 2006
  ident: 2023072603061035200_bib10
  article-title: Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.177.4.2671
– volume: 40
  start-page: 1725
  year: 1997
  ident: 2023072603061035200_bib8
  article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.1780400928
– volume: 43
  start-page: 1186
  year: 2011
  ident: 2023072603061035200_bib1
  article-title: Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus
  publication-title: Nat. Genet.
  doi: 10.1038/ng.975
– volume: 115
  start-page: 113
  year: 2012
  ident: 2023072603061035200_bib16
  article-title: Mapping lupus susceptibility genes in the NZM2410 mouse model
  publication-title: Adv. Immunol.
  doi: 10.1016/B978-0-12-394299-9.00004-7
– volume: 167
  start-page: 2354
  year: 2001
  ident: 2023072603061035200_bib13
  article-title: The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.167.4.2354
– volume: 101
  start-page: 1362
  year: 1998
  ident: 2023072603061035200_bib15
  article-title: Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes
  publication-title: J. Clin. Invest.
– volume: 97
  start-page: 6670
  year: 2000
  ident: 2023072603061035200_bib18
  article-title: Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains
  publication-title: Proc. Natl. Acad. Sci. USA.
  doi: 10.1073/pnas.97.12.6670
– start-page: 1
  volume-title: Lupus Nephritis.
  year: 2011
  ident: 2023072603061035200_bib6
  article-title: Clinical manifestations of lupus nephritis
– volume: 24
  start-page: 377
  year: 2003
  ident: 2023072603061035200_bib26
  article-title: T cells in glomerulonephritis
  publication-title: Springer Semin. Immunopathol.
  doi: 10.1007/s00281-003-0121-7
– volume: 64
  start-page: 2319
  year: 2012
  ident: 2023072603061035200_bib21
  article-title: Prevalence and sociodemographic correlates of antinuclear antibodies in the United States
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.34380
– volume: 56
  start-page: 493
  year: 1977
  ident: 2023072603061035200_bib14
  article-title: Lupus nephropathy without clinical renal involvement
  publication-title: Medicine (Baltimore).
  doi: 10.1097/00005792-197711000-00004
– volume: 36
  start-page: 63
  year: 2009
  ident: 2023072603061035200_bib28
  article-title: Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004
  publication-title: J. Rheumatol.
  doi: 10.3899/jrheum.080625
– volume: 98
  start-page: 1787
  year: 2001
  ident: 2023072603061035200_bib19
  article-title: The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes
  publication-title: Proc. Natl. Acad. Sci. USA.
  doi: 10.1073/pnas.98.4.1787
– volume: 161
  start-page: 378
  year: 1985
  ident: 2023072603061035200_bib31
  article-title: Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.161.2.378
– volume: 312
  start-page: 1665
  year: 2006
  ident: 2023072603061035200_bib12
  article-title: Regulation of B cell tolerance by the lupus susceptibility gene Ly108
  publication-title: Science.
  doi: 10.1126/science.1125893
– volume: 186
  start-page: 4994
  year: 2011
  ident: 2023072603061035200_bib3
  article-title: A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1003010
– volume: 64
  start-page: 797
  year: 2012
  ident: 2023072603061035200_bib7
  article-title: American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
  publication-title: Arthritis Care Res. (Hoboken).
  doi: 10.1002/acr.21664
– reference: 3919141 - J Exp Med. 1985 Feb 1;161(2):378-91
– reference: 14718514 - J Exp Med. 2004 Jan 19;199(2):255-64
– reference: 22129255 - N Engl J Med. 2011 Dec 1;365(22):2110-21
– reference: 22608257 - Adv Immunol. 2012;115:113-39
– reference: 10841565 - Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6670-5
– reference: 9502778 - J Clin Invest. 1998 Mar 15;101(6):1362-72
– reference: 11513551 - Clin Immunol. 2001 Sep;100(3):372-83
– reference: 17082757 - Kidney Int. 2007 Jan;71(1):74-8
– reference: 23392277 - Genes Immun. 2013 Apr;14(3):170-8
– reference: 16778059 - Science. 2006 Jun 16;312(5780):1665-9
– reference: 22237992 - Arthritis Rheum. 2012 Jul;64(7):2319-27
– reference: 11490025 - J Immunol. 2001 Aug 15;167(4):2354-60
– reference: 12778334 - Springer Semin Immunopathol. 2003 May;24(4):377-93
– reference: 7138600 - Arthritis Rheum. 1982 Nov;25(11):1271-7
– reference: 22019780 - Nat Genet. 2011 Dec;43(12):1186-8
– reference: 7889410 - Immunity. 1994 Jun;1(3):219-29
– reference: 18209092 - J Immunol. 2008 Feb 1;180(3):1938-47
– reference: 3890479 - Adv Immunol. 1985;37:269-390
– reference: 22556106 - Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808
– reference: 2544432 - Eur J Immunol. 1989 May;19(5):881-7
– reference: 335188 - Medicine (Baltimore). 1977 Nov;56(6):493-501
– reference: 11172029 - Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1787-92
– reference: 9324032 - Arthritis Rheum. 1997 Sep;40(9):1725
– reference: 19004042 - J Rheumatol. 2009 Jan;36(1):63-7
– reference: 17938927 - Semin Immunopathol. 2007 Nov;29(4):355-74
– reference: 12687552 - Arthritis Rheum. 2003 Apr;48(4):1080-92
– reference: 16301622 - J Immunol. 2005 Dec 1;175(11):7185-92
– reference: 16888029 - J Immunol. 2006 Aug 15;177(4):2671-80
– reference: 9461440 - Science. 1998 Feb 13;279(5353):1052-4
– reference: 18305268 - N Engl J Med. 2008 Feb 28;358(9):929-39
– reference: 17114504 - J Immunol. 2006 Dec 1;177(11):8258-65
– reference: 21411733 - J Immunol. 2011 Apr 15;186(8):4994-5003
SSID ssj0014456
Score 2.3085537
Snippet Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was...
The mechanisms regulating acute and chronic glomerulonephritis are dependent on different genetic mechanisms, where the Cgnz1 allele confers kidney protection...
The mechanisms regulating acute and chronic glomerulonephritis are dependent on different genetic mechanisms, where the Cgnz1 allele confers kidney protection...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2387
SubjectTerms Acute Disease
Alleles
Animals
Antigen-Antibody Complex - adverse effects
Autoantibodies - adverse effects
Capillaries - pathology
Capillaries - ultrastructure
Chromosomes, Mammalian - genetics
Dendritic Cells - metabolism
Dendritic Cells - pathology
Disease Progression
Disease Susceptibility
Endocytosis
Endothelial Cells - pathology
Endothelial Cells - ultrastructure
Female
Gene Expression Regulation
Humans
Immunity - immunology
Inflammation - immunology
Inflammation - pathology
Kidney - blood supply
Kidney - immunology
Kidney - pathology
Kidney - ultrastructure
Lupus Nephritis - immunology
Lupus Nephritis - pathology
Macrophages - metabolism
Macrophages - pathology
Mice
Mice, Inbred Strains
Proteins - metabolism
Proteinuria - metabolism
Proteinuria - pathology
Sheep
Vacuoles - pathology
Vacuoles - ultrastructure
Title Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex–mediated acute lupus glomerulonephritis
URI https://www.ncbi.nlm.nih.gov/pubmed/24101379
https://www.proquest.com/docview/1444392342
https://www.proquest.com/docview/1551640863
https://pubmed.ncbi.nlm.nih.gov/PMC3804943
Volume 210
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9NAFB7qCuKLeLfeGEGfStYmM01mHqWopVAR3YX6VCbJTLdsm5RuA7JPgj_Bf6h_xHMmk0u3q-hCCSWZdNqeL-cy5ztnCHlpjPGFMtoDcyI9iDe4FxuZelJJBa_Ij-02nZMP4eiYj6eDaafzq8VaKrbxYXJ-aV3JVaQK50CuWCX7H5KtPxROwHuQLxxBwnD8JxkP59m538PdUJaWdG6wGvd0kWbwoEMYja4hPrfgXqZqheSctWvYZCvQ83nJgbUO4wLrRHTJMNdfKwoEs4Ul6JSqBAkFy2JdnGETkZXeFMs80wAFbIrUdnGbYjPr5u5sIXAxk__eLqd-aRA6Xrj16-GJypuElVvTLjLvM1zvjQ-bBdi5gljAWpKRwmxUexnDt4S4oFnGwO_2CSyANpiv2OzVSbZ1OITPyO0oLZhT27yPiWjR1uuB48s6APttNc2clS9NPng1_qXmpC84mhONLQt81IY7wwAM65WFFrhB2LpRNka1pjp-nAyZwCY87Bq5HkAsYyvSpzUPCQJau8Vw_bNcdQZM_bo9MXatdrPsulB7cdFFem_LXzq6TW45BNA3JWrvkI7O7pIbEweAe-S7BS8twUsdeGkJXtqAl25zWoKXNuClLfDS3NASvNSB9-e3HxVsqYUttbCl-7C9T47fvT0ajjy3I4iXcMG2XiqVYSZM_chESsdcxmKgBEu4ioWIUx6zMOWDSAvN0lCwKAklH5gkgrtkotKIPSAHGczyiNDQmDTuC21k7HOTSKV1YKKBCsRASwg7uqRX_cmzxLXLx11bljNL2xB8BtKZVdLpklf16HXZJuYP415U8pqBHsfknMp0XpxBCM4hNggYD_4yBrPavC9C1iUPSxnXs1Xg6JJoR_r1AOwjv3slW5zYfvIOn4-vfOcTcrN5pJ-Sg-2m0M_AV9_Gzy3WfwOWXfWt
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cgnz1+allele+confers+kidney+resistance+to+damage+preventing+progression+of+immune+complex%E2%80%93mediated+acute+lupus+glomerulonephritis&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Ge%2C+Yan&rft.au=Jiang%2C+Chao&rft.au=Sung%2C+Sun-Sang+J.&rft.au=Bagavant%2C+Harini&rft.date=2013-10-21&rft.pub=The+Rockefeller+University+Press&rft.issn=0022-1007&rft.eissn=1540-9538&rft.volume=210&rft.issue=11&rft.spage=2387&rft.epage=2401&rft_id=info:doi/10.1084%2Fjem.20130731&rft_id=info%3Apmid%2F24101379&rft.externalDocID=PMC3804943
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon